Oral montelukast may have a role in severe and in life-threatening acute asthma

Archives of Disease in Childhood

Volumn 96, Issue 3, 2011, Pages 322-

  Jolobe, Oscar M P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; MONTELUKAST; PREDNISOLONE; SALBUTAMOL;

ADD ON THERAPY; ASTHMA; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXPIRATORY FLOW RATE; HOSPITAL ADMISSION; HUMAN; LETTER; LUNG FUNCTION; PRIORITY JOURNAL;

ACETATES; ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; HUMANS; QUINOLINES;

EID: 79951678610     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.205989     Document Type: Letter

References (3)

1. Capsomidis A, Tighe M. Archimedes. Question 2. Is oral montelukast beneficial in treating acute asthma exacerbations in children? Arch Dis Child 2010;95:948-50.
2. Ramsay CF, Pearson D, Mildenhall S, et al. Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial. Thorax 2011;66:7-11.
3. British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guidelines on the management of asthma. Thorax 2003;58(Suppl 1):i1-94.